BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25547389)

  • 1. Candesartan improves ischemia-induced impairment of the blood-brain barrier in vitro.
    So G; Nakagawa S; Morofuji Y; Hiu T; Hayashi K; Tanaka K; Suyama K; Deli MA; Nagata I; Matsuo T; Niwa M
    Cell Mol Neurobiol; 2015 May; 35(4):563-72. PubMed ID: 25547389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cilostazol strengthens barrier integrity in brain endothelial cells.
    Horai S; Nakagawa S; Tanaka K; Morofuji Y; Couraud PO; Deli MA; Ozawa M; Niwa M
    Cell Mol Neurobiol; 2013 Mar; 33(2):291-307. PubMed ID: 23224787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilostazol attenuates ischemia-reperfusion-induced blood-brain barrier dysfunction enhanced by advanced glycation endproducts via transforming growth factor-β1 signaling.
    Takeshita T; Nakagawa S; Tatsumi R; So G; Hayashi K; Tanaka K; Deli MA; Nagata I; Niwa M
    Mol Cell Neurosci; 2014 May; 60():1-9. PubMed ID: 24472843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient oxygen-glucose deprivation sensitizes brain capillary endothelial cells to rtPA at 4h of reoxygenation.
    Kuntz M; Mysiorek C; Pétrault O; Boucau MC; Aijjou R; Uzbekov R; Bérézowski V
    Microvasc Res; 2014 Jan; 91():44-57. PubMed ID: 24333620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Rho-kinase protects cerebral barrier from ischaemia-evoked injury through modulations of endothelial cell oxidative stress and tight junctions.
    Gibson CL; Srivastava K; Sprigg N; Bath PM; Bayraktutan U
    J Neurochem; 2014 Jun; 129(5):816-26. PubMed ID: 24528233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral hypoxia/ischemia selectively disrupts tight junctions complexes in stem cell-derived human brain microvascular endothelial cells.
    Page S; Munsell A; Al-Ahmad AJ
    Fluids Barriers CNS; 2016 Oct; 13(1):16. PubMed ID: 27724968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fasudil on blood-brain barrier integrity.
    Sato K; Nakagawa S; Morofuji Y; Matsunaga Y; Fujimoto T; Watanabe D; Izumo T; Niwa M; Walter FR; Vigh JP; Santa-Maria AR; Deli MA; Matsuo T
    Fluids Barriers CNS; 2022 Jun; 19(1):43. PubMed ID: 35659272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells.
    Zhu H; Wang Z; Xing Y; Gao Y; Ma T; Lou L; Lou J; Gao Y; Wang S; Wang Y
    J Ethnopharmacol; 2012 Jun; 141(2):714-20. PubMed ID: 21920425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial contact of glioblastoma cells with existing normal brain endothelial cells strengthen the barrier function via fibroblast growth factor 2 secretion: a new in vitro blood-brain barrier model.
    Toyoda K; Tanaka K; Nakagawa S; Thuy DH; Ujifuku K; Kamada K; Hayashi K; Matsuo T; Nagata I; Niwa M
    Cell Mol Neurobiol; 2013 May; 33(4):489-501. PubMed ID: 23385422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geniposide protects against hypoxia/reperfusion-induced blood-brain barrier impairment by increasing tight junction protein expression and decreasing inflammation, oxidative stress, and apoptosis in an in vitro system.
    Li C; Wang X; Cheng F; Du X; Yan J; Zhai C; Mu J; Wang Q
    Eur J Pharmacol; 2019 Jul; 854():224-231. PubMed ID: 30995438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plant-derived triterpene celastrol ameliorates oxygen glucose deprivation-induced disruption of endothelial barrier assembly via inducing tight junction proteins.
    Luo D; Zhao J; Rong J
    Phytomedicine; 2016 Dec; 23(13):1621-1628. PubMed ID: 27823626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro analysis of drugs that improve hyperglycemia-induced blood-brain barrier dysfunction.
    Kayano R; Morofuji Y; Nakagawa S; Fukuda S; Watanabe D; Ozawa H; Niwa M; Matsuo T
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1885-1890. PubMed ID: 30060956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligustilide Ameliorates the Permeability of the Blood-Brain Barrier Model In Vitro During Oxygen-Glucose Deprivation Injury Through HIF/VEGF Pathway.
    Wu S; Wang N; Li J; Wang G; Seto SW; Chang D; Liang H
    J Cardiovasc Pharmacol; 2019 May; 73(5):316-325. PubMed ID: 30855407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of preconditioning on tight junction and cell adhesion of cerebral endothelial cells.
    An P; Xue YX
    Brain Res; 2009 May; 1272():81-8. PubMed ID: 19332028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilostazol ameliorates ischemia/reperfusion-induced tight junction disruption in brain endothelial cells by inhibiting endoplasmic reticulum stress.
    Nan D; Jin H; Deng J; Yu W; Liu R; Sun W; Huang Y
    FASEB J; 2019 Sep; 33(9):10152-10164. PubMed ID: 31184927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue plasminogen activator enhances the hypoxia/reoxygenation-induced impairment of the blood-brain barrier in a primary culture of rat brain endothelial cells.
    Hiu T; Nakagawa S; Hayashi K; Kitagawa N; Tsutsumi K; Kawakubo J; Honda M; Suyama K; Nagata I; Niwa M
    Cell Mol Neurobiol; 2008 Dec; 28(8):1139-46. PubMed ID: 18629628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ruscogenin Attenuates Cerebral Ischemia-Induced Blood-Brain Barrier Dysfunction by Suppressing TXNIP/NLRP3 Inflammasome Activation and the MAPK Pathway.
    Cao G; Jiang N; Hu Y; Zhang Y; Wang G; Yin M; Ma X; Zhou K; Qi J; Yu B; Kou J
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of MicroRNA-155 Supports Endothelial Tight Junction Integrity Following Oxygen-Glucose Deprivation.
    Pena-Philippides JC; Gardiner AS; Caballero-Garrido E; Pan R; Zhu Y; Roitbak T
    J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29945912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygen-glucose deprivation and reoxygenation as an in vitro ischemia-reperfusion injury model for studying blood-brain barrier dysfunction.
    Alluri H; Anasooya Shaji C; Davis ML; Tharakan B
    J Vis Exp; 2015 May; (99):e52699. PubMed ID: 25992584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tanshinone IIA protects the human blood-brain barrier model from leukocyte-associated hypoxia-reoxygenation injury.
    Zhang WJ; Feng J; Zhou R; Ye LY; Liu HL; Peng L; Lou JN; Li CH
    Eur J Pharmacol; 2010 Dec; 648(1-3):146-52. PubMed ID: 20826144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.